Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: Monitoring and management guidelines

Seminars in Hematology

Volumn 49, Issue 1, 2012, Pages 73-82

  Abboud, Imad ^a   Peraldi, Marie Noëlle ^a   Hingorani, Sangeeta ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Seattle Children's   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CAPTOPRIL; CIDOFOVIR; CONTRAST MEDIUM; CYCLOSPORIN; DEFIBROTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB; TACROLIMUS;

ACUTE KIDNEY FAILURE; ALBUMINURIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD PRESSURE MONITORING; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG USE; ECHOGRAPHY; GRAFT VERSUS HOST REACTION; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SODIUM RESTRICTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUBULAR DYSFUNCTION; VIRUS INFECTION; VIRUS NEPHROPATHY;

CHRONIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY DISEASES; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SURVIVORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855360868     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2011.10.008     Document Type: Article

References (80)

1. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999, 341:14-21.
2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266. National Kidney Foundation.
3. Cohen E.P., Lawton C.A., Moulder J.E. Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 1995, 70:217-222.
4. Weiss A.S., Sandmaier B.M., Storer B., Storb R., McSweeney P.A., Parikh C.R. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006, 6:89-94.
5. Hingorani S., Guthrie K.A., Schoch G., Weiss N.S., McDonald G.B. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007, 39:223-229.
6. Hingorani S., Guthrie K., Schoch G., McDonald G. Risk factors for chronic kidney disease after hematopoietic cell transplant. Biol Blood Marrow Transplant 2005, 11 Suppl 1:72-73.
7. Tarbell N.J., Guinan E.C., Niemeyer C., Mauch P., Sallan S.E., Weinstein H.J. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988, 15:99-104.
8. Leung W., Ahn H., Rose S.R., et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007, 86:215-224.
9. Ando M., Ohashi K., Akiyama H., et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 2010, 25:278-282.
10. Cohen E.P., Piering W.F., Kabler-Babbitt C., Moulder J.E. End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compar ed to other causes of ESRD. Nephron 1998, 79:408-412.
11. Bergstein J., Andreoli S.P., Provisor A.J., Yum M. Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 1986, 41:63-66.
12. Pettitt A.R., Clark R.E. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994, 14:495-504.
13. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
14. Miralbell R., Bieri S., Mermillod B., et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996, 14:579-585.
15. Abboud I., Porcher R., Robin M., et al. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:1251-1257.
16. Moake J.L. Thrombotic microangiopathies. N Engl J Med 2002, 347:589-600.
17. Ho V.T., Cutler C., Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:571-575.
18. Paquette R.L., Tran L., Landaw E.M. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998, 22:351-357.
19. Uderzo C., Fumagalli M., De Lorenzo P., et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 2000, 26:1005-1009.
20. Van Why S.K., Friedman A.L., Wei L.J., Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 1991, 7:383-388.
21. Antignac C., Gubler M.C., Leverger G., Broyer M., Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989, 35:1336-1344.
22. Berg U., Bolme P. Renal function in children following bone marrow transplantation. Transplant Proc 1989, 21:3092-3094.
23. Lawton C.A., Cohen E.P., Murray K.J., et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 1997, 20:1069-1074.
24. Schriber J.R., Herzig G.P. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997, 34:126-133.
25. Atkinson K., Biggs J.C., Hayes J., et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 1983, 54:59-67.
26. Zeigler Z.R., Rosenfeld C.S., Andrews D.F., et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996, 53:213-220.
27. Chappell M.E., Keeling D.M., Prentice H.G., Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?. Bone Marrow Transplant 1988, 3:339-347.
28. Sarkodee-Adoo C., Sotirescu D., Sensenbrenner L., et al. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 2003, 43:78-84.
29. Fuge R., Bird J.M., Fraser A., et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001, 113:58-64.
30. Daly A.S., Hasegawa W.S., Lipton J.H., Messner H.A., Kiss T.L. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. Transfus Apher Sci 2002, 27:3-12.
31. Rao P.S. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 2005, 45:780-785.
32. Brukamp K., Doyle A.M., Bloom R.D., Bunin N., Tomaszewski J.E., Cizman B. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?. Clin J Am Soc Nephrol 2006, 1:685-694.
33. Debiec H., Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011, 364:689-690.
34. Petropoulou A.D., Robin M., Rocha V., et al. Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation. Transplantation 2010, 90:801-802.
35. Chan G.S., Lam M.F., Au W.Y., et al. IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation. Histopathology 2004, 45:648-651.
36. Suehiro T., Masutani K., Yokoyama M., et al. Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin Nephrol 2002, 58:231-237.
37. Nouri-Majelan N., Sanadgol H., Ghafari A., et al. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Transplant Proc 2005, 37:3213-3215.
38. Chien Y.H., Lin K.H., Lee T.Y., Lu M.Y., Tsau Y.K. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. J Formos Med Assoc 2000, 99:503-506.
39. Hingorani S.R., Guthrie K., Batchelder A., et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 2005, 67:272-277.
40. Kogon A., Hingorani S. Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol 2010, 30:615-626.
41. Kist-van Holthe J.E., van Zwet J.M., Brand R., van Weel M.H., Vossen J.M., van der Heijden A.J. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998, 22:559-564.
42. Hirsch H.H., Brennan D.C., Drachenberg C.B., et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005, 79:1277-1286.
43. Hatakeyama N., Suzuki N., Kudoh T., Hori T., Mizue N., Tsutsumi H. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003, 22:928-929.
44. Verghese P.S., Finn L.S., Englund J.A., Sanders J.E., Hingorani S.R. BK nephropathy in pediatric hematopoietic stem cell transplant recipients. Pediatr Transplant 2009, 13:913-918.
45. Stracke S., Helmchen U., von Muller L., Bunjes D., Keller F. Polyoma virus-associated interstitial nephritis in a patient with acute myeloic leukaemia and peripheral blood stem cell transplantation. Nephrol Dial Transplant 2003, 18:2431-2433.
46. Kist-van Holthe J.E., Goedvolk C.A., Brand R., et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002, 17:1032-1037.
47. Hoffmeister P.A., Hingorani S.R., Storer B.E., Baker K.S., Sanders J.E. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:515-524.
48. Majhail N.S., Challa T.R., Mulrooney D.A., Baker K.S., Burns L.J. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009, 15:1100-1107.
49. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
50. McNiece K.L., Poffenbarger T.S., Turner J.L., Franco K.D., Sorof J.M., Portman R.J. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007, 150:640-644.
51. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
52. Hingorani S.R., Seidel K., Lindner A., Aneja T., Schoch G., McDonald G. Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 2008, 14:1365-1372.
53. Abbate M., Zoja C., Remuzzi G. How does proteinuria cause progressive renal damage?. J Am Soc Nephrol 2006, 17:2974-2984.
54. Patzer L., Ringelmann F., Kentouche K., et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 2001, 27:319-327.
55. Rizzo J.D., Wingard J.R., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006, 12:138-151.
56. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
57. Seronie-Vivien S., Toullec S., Malard L., Thomas F., Durrand V., Chatelut E. Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients. Med Oncol 2006, 23:63-73.
58. Chang A., Hingorani S., Kowalewska J., et al. Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007, 2:1014-1023.
59. Terrier B., Delmas Y., Hummel A., et al. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant 2007, 22:1369-1376.
60. Reddy P., Johnson K., Uberti J.P., et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006, 38:351-357.
61. Christidou F., Athanasiadou A., Kalogiannidis P., et al. Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience. Ther Apher Dial 2003, 7:259-262.
62. Oran B., Donato M., Aleman A., et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant 2007, 13:469-477.
63. Au W., Ma E., Lee T., et al. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 2007, 137:475-478.
64. Corti P., Uderzo C., Tagliabue A., et al. Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2002, 29:542-543.
65. Cohen E.P. Radiation nephropathy after bone marrow transplantation. Kidney Int 2000, 58:903-918.
66. Cohen E., Irving A., Drobyski W., et al. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 2008, 70:1546-1551.
67. Dagenais N.J., Jamali F. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Pharmacotherapy 2005, 25:1213-1229.
68. Butcher J.A., Hariharan S., Adams M.B., Johnson C.P., Roza A.M., Cohen E.P. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 1999, 13:330-335.
69. Beitinjaneh A., Burns L.J., Majhail N.S. Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review. Clin Transplant 2010, 24:E94-E102.
70. Al-Hazzouri A., Cao Q., Burns L.J., Weisdorf D.J., Majhail N.S. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008, 14:658-663.
71. Choi M., Sun C.L., Kurian S., et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 2008, 113:1580-1587.
72. Delgado J., Cooper N., Thomson K., et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006, 12:75-83.
73. Frisk P., Bratteby L.E., Carlson K., Lonnerholm G. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2002, 29:129-136.
74. Gronroos M.H., Bolme P., Winiarski J., Berg U.B. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 2007, 39:717-723.
75. Kersting S., Verdonck L.F. Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 2008, 14:403-408.
76. Kist-van Holthe J.E., Bresters D., Ahmed-Ousenkova Y.M., et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 2005, 36:605-610.
77. Leblond V., Sutton L., Jacquiaud C., et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 1995, 6:1661-1665.
78. Lonnerholm G., Carlson K., Bratteby L.E., et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991, 8:129-134.
79. Miralbell R., Sancho G., Bieri S., et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Int J Radiat Oncol Biol Phys 2004, 58:809-816.
80. Touzot M., Elie C., van Massenhove J., Maillard N., Buzyn A., Fakhouri F. Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study. Nephrol Dial Transplant 2010, 25:624-627.